Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heliocare is a leading professional dermo-cosmetic brand specializing in advanced sun protection, owned by the Spanish pharmaceutical company Cantabria Labs. The brand is built around its proprietary Fernblock technology, a standardized extract of the fern Polypodium leucotomos that provides oral and topical photo-immunoprotection. Heliocare products are designed to protect the skin against four types of radiation—UVA, UVB, Visible, and Infrared—while repairing DNA damage and preventing premature aging. The portfolio includes a wide range of topical sunscreens and oral supplements widely recommended by dermatologists globally. Its clinical efficacy is supported by numerous studies published in high-impact scientific journals, making it a benchmark in the field of photobiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HELIOCARE.